Video Upload Options

References

1. Dadi H, Jones TA, Merico D, Sharfe N, Ovadia A, Schejter Y, Reid B, Sun M,Vong L, Atkinson A, Lavi S, Pomerantz JL, Roifman CM. Combined immunodeficiencyand atopy caused by a dominant negative mutation in caspase activation andrecruitment domain family member 11 (CARD11). J Allergy Clin Immunol. 2018May;141(5):1818-1830.e2. doi: 10.1016/j.jaci.2017.06.047.
2. Greil J, Rausch T, Giese T, Bandapalli OR, Daniel V, Bekeredjian-Ding I, StützAM, Drees C, Roth S, Ruland J, Korbel JO, Kulozik AE. Whole-exome sequencinglinks caspase recruitment domain 11 (CARD11) inactivation to severe combinedimmunodeficiency. J Allergy Clin Immunol. 2013 May;131(5):1376-83.e3. doi:10.1016/j.jaci.2013.02.012.
3. Kogure Y, Kataoka K. Genetic alterations in adult T-cell leukemia/lymphoma.Cancer Sci. 2017 Sep;108(9):1719-1725. doi: 10.1111/cas.13303.Review.
4. Lamason RL, McCully RR, Lew SM, Pomerantz JL. Oncogenic CARD11 mutationsinduce hyperactive signaling by disrupting autoinhibition by the PKC-responsiveinhibitory domain. Biochemistry. 2010 Sep 28;49(38):8240-50. doi:10.1021/bi101052d.
5. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM,Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM.Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008 Mar 21;319(5870):1676-9. doi: 10.1126/science.1153629.
6. Ma CA, Stinson JR, Zhang Y, Abbott JK, Weinreich MA, Hauk PJ, Reynolds PR,Lyons JJ, Nelson CG, Ruffo E, Dorjbal B, Glauzy S, Yamakawa N, Arjunaraja S, VossK, Stoddard J, Niemela J, Zhang Y, Rosenzweig SD, McElwee JJ, DiMaggio T,Matthews HF, Jones N, Stone KD, Palma A, Oleastro M, Prieto E, Bernasconi AR,Dubra G, Danielian S, Zaiat J, Marti MA, Kim B, Cooper MA, Romberg N, Meffre E,Gelfand EW, Snow AL, Milner JD. Germline hypomorphic CARD11 mutations in severeatopic disease. Nat Genet. 2017 Aug;49(8):1192-1201. doi: 10.1038/ng.3898.
7. Shi JH, Sun SC. TCR signaling to NF-κB and mTORC1: Expanding roles of theCARMA1 complex. Mol Immunol. 2015 Dec;68(2 Pt C):546-57. doi:10.1016/j.molimm.2015.07.024.
8. Snow AL, Xiao W, Stinson JR, Lu W, Chaigne-Delalande B, Zheng L, Pittaluga S, Matthews HF, Schmitz R, Jhavar S, Kuchen S, Kardava L, Wang W, Lamborn IT, JingH, Raffeld M, Moir S, Fleisher TA, Staudt LM, Su HC, Lenardo MJ. Congenital Bcell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med. 2012 Nov 19;209(12):2247-61. doi: 10.1084/jem.20120831.
9. Thome M, Charton JE, Pelzer C, Hailfinger S. Antigen receptor signaling toNF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol. 2010Sep;2(9):a003004. doi: 10.1101/cshperspect.a003004.
10. Turvey SE, Durandy A, Fischer A, Fung SY, Geha RS, Gewies A, Giese T, Greil J,Keller B, McKinnon ML, Neven B, Rozmus J, Ruland J, Snow AL, Stepensky P, WarnatzK. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency. J Allergy Clin Immunol. 2014Aug;134(2):276-84. doi: 10.1016/j.jaci.2014.06.015. Review.